Endo45 is a symptom tracking and habit-building app for individuals managing endometriosis and chronic pelvic pain, available on iOS and Android.
The App DNA
What makes this app unique?
The app removes the cognitive load of manual symptom logging by providing a centralized, evidence-informed roadmap that helps users identify patterns between daily habits and pain flares.
For Individuals navigating endometriosis, adenomyosis, or chronic pelvic pain who seek evidence-based self-management tools between medical appointments.
What does it look like?
Key features
Personalized rating tracking progress across pain, energy, digestion, and mood metrics.
Customized habit-building plan based on individual priorities and capacity.
Logs for pelvic pain, period cycles, fatigue, and bloating patterns.
How much does it cost?
Subscription-only model anchored at $14.99/month, utilizing a 7-day free trial to lower the barrier to entry.
Velocity
Maintenance developmentperformanceopaqueShow more...
Endo45 maintains a maintenance-level cadence, shipping approximately 0.12 releases per week. The latest updates across iOS and Android have been limited to minor security patches and generic stability improvements rather than new features. Development appears focused on backend maintenance rather than expanding the app's core functionality. The current release pattern suggests a stable but slow development cycle.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans frustrated. Users appreciate educational content regarding endometriosis management provides actionable techniques for users seeking symptom relief and health tracking and visual progress tracking through graphs helps users monitor their health journey and symptom reduction over time.
How are ratings & reviews evolving?
What users say, by theme
- Educational content regarding endometriosis management provides actionable techniques for users seeking symptom relief and health tracking
- Visual progress tracking through graphs helps users monitor their health journey and symptom reduction over time
- Aggressive paywalls immediately upon account creation prevent users from evaluating the app before committing to subscriptions
17 of 17 recent reviews analyzed · moderate confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Endometriosis Tracker: Endo45
How's the Health & Fitness market?
Endo45 holds a niche position in the Health & Fitness category, currently ranking #21 Grossing in New Zealand. The high price point relative to general health trackers signals a focus on high-intent users managing chronic conditions.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Endometriosis Tracker: Endo45
Where is it heading?
The endometriosis management market is consolidating around tools that offer both symptom tracking and actionable, evidence-based lifestyle guidance. Endo45 is well-positioned to capture this segment if it can resolve its technical debt and lower the initial barrier to entry, as the current maintenance-mode cadence leaves it vulnerable to more stable, feature-rich competitors.
- Technical instability on Android (login loops, broken navigation) prevents consistent access to paid features, which directly drives negative sentiment.
- The EndoFit™ Score provides a clear, measurable value proposition that differentiates Endo45 from standard period trackers, supporting long-term retention.
The SWOT
- EndoFit™ Score quantifies invisible progress, creating a defensible barrier against generic trackers.
- Evidence-informed roadmap provides structured support between medical appointments.
- Localized tracking for comorbidities like adenomyosis could capture underserved segments.
Next best moves
Remove immediate paywall for a 7-day feature-limited trial because user reviews flag it as a primary barrier to entry → increase new-user conversion.
+ 1 more prioritized moveThe counter-intuitive read
The immediate paywall is a strategic error: in the chronic pain space…
Read the full takeSince the last report: The outlook for Endo45 shifted from declining to mixed, driven by a clearer articulation of its value proposition against generic trackers despite ongoing technical instability.
Bottom line
Endo45 provides high-value health tracking, but the immediate paywall and technical instability prevent it from scaling beyond a niche audience. Addressing the Android login failures and softening the entry barrier would unlock the retention potential of the EndoFit™ Score.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store listing, source
Report last updated